Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SM-020 Gel for Seborrheic Keratosis
NCT05136144Phase 2Active, not recruiting
- Sponsor
- DermBiont, Inc.
- Start
- Oct 2021
- Primary completion
- May 2024
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SM-020 in seborrheic keratosis (SK), sponsored by DermBiont, Inc.. Started Oct 2021; status: active, not recruiting.
02
Drugs
SM-020
03
Conditions
seborrheic keratosis (SK)
Beyond the preview
Go deeper on NCT05136144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05136144.